Vorsetuzumab-mafodotin

An antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody, directed against the extracellular domain of the human CD70 molecule, conjugated to the auristatin analogue monomethyl auristatin phenylalanine (MMAF), with potential antineoplastic activity. The anti-CD70 antibody moiety of vorsetuzumab-mafodotin selectively binds to the extracellular domain of CD70 on tumor cell surfaces. Upon internalization, the MMAF moiety is released, binds to tubulin and inhibits its polymerization, which may result in G2/M phase arrest, tumor cell apoptosis and inhibition of cellular proliferation in tumor cells that overexpress CD70. CD70, the ligand for the costimulatory receptor CD27 and a member of the tumor necrosis factor (TNF) family, is found on the surfaces of various types of cancer cells. (NCI Thesaurus)

YOU MAY ALSO LIKE

Vorozole

A hormone therapy drug used to decrease the production of estrogen.

Vorinostat

A drug that is used to treat cutaneous T-cell lymphoma that does not get better, gets worse, or comes back during or…

Voriconazole

A drug that treats infections caused by fungi.

Voraxaze

A drug used to treat toxic levels of methotrexate (an anticancer drug) in the blood of patients with kidney problems. It is…

von Willebrand Factor Measurement

The determination of the amount of von Willebrand factor present in a sample.

Von Willebrand Factor A Domain

The type A domain (vWF) of the von Willebrand factor, a large multimeric glycoprotein found in blood plasma, is the prototype for…